BioCentury
ARTICLE | Clinical News

Visudyne verteporfin injection regulatory update

February 12, 2001 8:00 AM UTC

QLT and partner Novartis Ophthalmics (Bulach, Switzerland) said the FDA issued an approvable letter for Visudyne to treat predominantly classic subfoveal choroidal neovascularization (CNV) caused by p...